Literature DB >> 3368039

Characteristics of 125I-Bolton-Hunter labelled cholecystokinin binding in human brain.

A J Cross1, P Slater, W Skan.   

Abstract

The high affinity binding of 125I-Bolton-Hunter labelled CCK-8 (125I-BHCCK) was studied in human brain using ligand binding and autoradiographic techniques. High levels of 125I-BHCCK binding were observed in cortex, striatum and cerebellum. In cerebellar membranes 125I-BHCCK binding was inhibited by CCK analogues with an order of potency, caerulein greater than CCK-8 greater than CCK-33 greater than gastrin 1-17 = CCK-8 non-sulphated. CCK-4 was inactive. It is suggested that in human brain 125I-BHCCK labels a population of CCK receptors similar to those observed in guinea pig brain. The properties and distribution of these receptors differ from those of rat brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3368039     DOI: 10.1016/0143-4179(88)90013-3

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  1 in total

1.  Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum.

Authors:  M D'Amato; I F Stamford; A Bennett
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.